Drug intelligence / Profile preview

perindopril tert-butylamine

Development stage
Approved
Lead developer
Servier
Modality
Small Molecules
Administration
Oral
01

Overview

Perindopril tert-butylamine is an **angiotensin-converting enzyme (ACE) inhibitor** used primarily to treat hypertension (high blood pressure), heart failure, and to reduce cardiovascular risk in patients with stable coronary artery disease. As a prodrug, it is converted in the body to the active metabolite, perindoprilat, which inhibits ACE, reducing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This results in vasodilation and decreased blood pressure. Additional effects include decreased aldosterone secretion and inhibition of kininase II, which may increase bradykinin levels. It is often used as monotherapy or in combination with other drugs like indapamide (a thiazide-like diuretic) or amlodipine (a calcium channel blocker) to enhance antihypertensive effects.

Brand names
Acertil
Other names
perindoprilperindoprilum tert-butylamineperindopril tert-butylaminperindopril tert-butylamine Servier
02

Targets

ACE C-domain (Angiotensin-converting enzyme C-domain)

Beyond the preview

Go deeper on perindopril tert-butylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perindopril tert-butylamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call